Top news July 2023: FDA approves leadless pacing system, AHA statement on vaping and more
Click Here to Manage Email Alerts
Healio | Cardiology Today has compiled a list of the top headlines in cardiology of July 2023.
Readers were interested in the approval of the first dual-chamber leadless pacing system; an American Heart Association scientific statement on e-cigarettes and vaping products; a tribute to William C. Roberts, MD; and more.
Image: Adobe Stock
FDA approves first dual-chamber leadless pacing system
Abbott announced that the FDA approved the world’s first dual-chamber leadless pacing system, which will open up leadless pacemaker technology to a broader population. Read more
AHA: E-cigarettes, vaping products may pose dangerous risks for heart, lungs
Emerging data suggest e-cigarettes and vaping products could increase risk for CV and pulmonary events and are not a “safe” alternative to combustible cigarettes, according to a new scientific statement from the AHA. Read more
Healthy diet including full-fat dairy lowers risk for heart disease, death worldwide
Researchers reported that a diet composed of higher amounts of fruit, vegetables, nuts, legumes, fish and whole-fat dairy is associated with lower CVD and mortality in all world regions, especially in countries with lower income. Read more
Carpal tunnel syndrome may be early predictor of heart failure risk
Adults with a diagnosis of carpal tunnel syndrome are 39% more likely to develop HF during 10 years of follow-up, especially amyloidosis, compared with those without a carpal tunnel syndrome diagnosis, researchers reported. Read more
High cholesterol common for adults with coronary artery disease, even with statin use
Most U.S. adults with coronary artery disease are not meeting guideline-recommended LDL targets, even when prescribed statin therapy, according to an analysis of nationwide survey data. Read more
A tribute to William C. Roberts, MD
Former Healio | Cardiology Today Editorial Board Member William C. Roberts, MD, MACC, a leading cardiovascular pathologist and longtime editor of two leading medical journals, died June 15 at his home in Dallas. Read more
Bakris: Take time, follow guidelines for accurate BP measurements
An accurate BP measurement is essential to properly diagnose and manage hypertension, yet most providers do not have time to follow the guideline-recommended steps, according to a speaker. Read more
FDA expands inclisiran indication to primary prevention patients
The FDA approved a label update for inclisiran to include people with elevated LDL and other risk factors such as hypertension and diabetes who have not experienced a CV event, Novartis announced. Read more
Beyond type 2 diabetes, metformin may also offer heart benefits
Experimental and clinical evidence suggest the diabetes drug metformin may offer CV benefits that do not depend on the presence of diabetes, and an ongoing trial will help researchers learn more. Read more
Value of lifestyle, symptom relief underscored in new chronic coronary disease guidelines
Updates on beta-blocker use, revascularization and routine testing and recommendations on healthy lifestyle are among the highlights of a new guideline on the management of patients with chronic coronary disease. Read more
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts